Strategic partnerships There is a history of exclusive distributor agreements and international partnerships (notably with PDI International and WellSky), indicating Brennan & Co values channel distribution and collaboration. This suggests opportunities to expand through strategic alliances, co-marketing, or representing additional compatible medical device lines in Ireland.

Healthcare focus The company positions itself as a major supplier to scientific, medical, and industrial markets with ongoing product line investment. This signals potential cross-sell of new medical devices and related equipment to existing healthcare and research customers, especially where complex, high-tech solutions are required.

Growth via branding Recent rebranding and identity launch alongside group-level expansion imply a marketing-friendly posture and willingness to invest in brand-driven demand generation. Targeted outreach could leverage their professional service ethos to win RFPs and procurement cycles in hospitals, labs, and industrial facilities.

Tech-enabled selling Portfolio includes diverse tech stack elements and Cloud/IT oriented tools (SQL, Intune, Cloudflare, Sage), suggesting capacity to support sophisticated customers with integrated software-enabled hardware solutions. There is potential to upsell data-enabled devices, instrumentation with software, and managed services.

Revenue growth potential Current revenue range ($1M-$10M) and mid-size employee base indicate room to scale through expanded distribution, service contracts, and extended product lines. Focused account-based selling to Irish healthcare providers, research institutes, and industrial customers could unlock higher-margin opportunities.